These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29183231)

  • 41. DEEPCYPs: A deep learning platform for enhanced cytochrome P450 activity prediction.
    Ai D; Cai H; Wei J; Zhao D; Chen Y; Wang L
    Front Pharmacol; 2023; 14():1099093. PubMed ID: 37101544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A support vector machine approach to classify human cytochrome P450 3A4 inhibitors.
    Kriegl JM; Arnhold T; Beck B; Fox T
    J Comput Aided Mol Des; 2005 Mar; 19(3):189-201. PubMed ID: 16059671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inhibitory effect of imperatorin and isoimperatorin on activity of cytochrome P450 enzyme in human and rat liver microsomes].
    Cao Y; Zhong YH; Yuan M; Li H; Zhao CJ
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1237-41. PubMed ID: 23944042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.
    Fang J; Yang R; Gao L; Zhou D; Yang S; Liu AL; Du GH
    J Chem Inf Model; 2013 Nov; 53(11):3009-20. PubMed ID: 24144102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes.
    Olesen OV; Linnet K
    Pharmacology; 1997 Nov; 55(5):235-43. PubMed ID: 9399333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults.
    Ma JD; Nafziger AN; Villano SA; Gaedigk A; Bertino JS
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1130-5. PubMed ID: 16569820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification models for CYP450 3A4 inhibitors and non-inhibitors.
    Choi I; Kim SY; Kim H; Kang NS; Bae MA; Yoo SE; Jung J; No KT
    Eur J Med Chem; 2009 Jun; 44(6):2354-60. PubMed ID: 19026469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.
    Zhang H; Ya G; Rui H
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):89-98. PubMed ID: 26874845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.
    Shi H; Tian S; Li Y; Li D; Yu H; Zhen X; Hou T
    Chem Res Toxicol; 2015 Jan; 28(1):116-25. PubMed ID: 25495542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Silico Prediction of Chemical Toxicity Profile Using Local Lazy Learning.
    Lu J; Zhang P; Zou XW; Zhao XQ; Cheng KG; Zhao YL; Bi Y; Zheng MY; Luo XM
    Comb Chem High Throughput Screen; 2017; 20(4):346-353. PubMed ID: 28215144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QSAR analysis of the inhibition of recombinant CYP 3A4 activity by structurally diverse compounds using a genetic algorithm-combined partial least squares method.
    Wanchana S; Yamashita F; Hashida M
    Pharm Res; 2003 Sep; 20(9):1401-8. PubMed ID: 14567634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.
    Yale SH; Glurich I
    J Altern Complement Med; 2005 Jun; 11(3):433-9. PubMed ID: 15992226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of cytochrome P450-mediated drug-drug interaction potential of orteronel and exposure changes in patients with renal impairment using physiologically based pharmacokinetic modeling and simulation.
    Lu C; Suri A; Shyu WC; Prakash S
    Biopharm Drug Dispos; 2014 Dec; 35(9):543-52. PubMed ID: 25264242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Line-walking method for predicting the inhibition of P450 drug metabolism.
    Hudelson MG; Jones JP
    J Med Chem; 2006 Jul; 49(14):4367-73. PubMed ID: 16821796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
    Dinger J; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2014 Jul; 406(18):4453-64. PubMed ID: 24830396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
    Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
    Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
    Kemp CA; Flanagan JU; van Eldik AJ; Maréchal JD; Wolf CR; Roberts GC; Paine MJ; Sutcliffe MJ
    J Med Chem; 2004 Oct; 47(22):5340-6. PubMed ID: 15481972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.